Rtw Investments, Lp bought $8.0M of Kailera Therapeutics (KLRA)

Executed Apr 20, disclosed Apr 22, 2 days later.

Value, as filed

$8.0M

500,000 sh × $16.00

Executed

Apr 20

the trade date, as filed

Disclosed

Apr 22

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

-20.3%

-26.2% from execution

Over the 21 trading sessions from the disclosed entry session (Apr 22), the stock returned -20.3% (delay-adjusted); from the execution session (Apr 20), -26.2%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

RL Rtw Investments, Lp 10% owner profile →

Rtw Investments, Lp (10% owner) filed 1 Form 4 report as a reporting entity in the trailing twelve months (1 purchase, 0 sales), most often in KLRA. Across 1 priced purchase filing, the average 21-session return was -26.2% from execution and -20.3% from disclosure (delay-adjusted; derived). The largest single filing was $8.0M of KLRA (500,000 sh × $16.00, as filed), executed Apr 20.

The name

KLRA KLRA KLRA · 5 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→